CoreTrust Expands International Presence, Extends Global Procurement Platform Across Europe
9.9.2026 14:00:00 CEST | Business Wire | Press Release
CoreTrust, a premier group purchasing organization (GPO) with more than 20 years of leveraging data-driven procurement intelligence and $7 billion in aggregated spend, today announced the expansion of CoreTrust Europe and its procurement platform to the United Kingdom and key European markets, including France, Germany, Ireland, the Netherlands, Sweden, and Switzerland. While members can enroll when headquartered in these seven markets, CoreTrust’s supplier partners deliver negotiated coverage that reaches members well beyond them. This strategic international expansion answers direct demand from CoreTrust’s private equity partners and multinational members to extend the company’s proven model into large, still-underserved European markets — the same demand-led path CoreTrust has followed for nearly two decades in the United States.
CoreTrust Europe features nine trusted supplier partners across core indirect spend categories — including Dell, FedEx, and Lyreco, among others — enabling CoreTrust members to access negotiated contracts, consistent governance, and scalable procurement support across the UK and Europe more broadly, with several supplier partners already delivering pricing and service in ten or more countries. This expansion also reflects broader market momentum, as several of the company's established supplier partners scale their own operations across Europe, CoreTrust extending alongside them is a natural next step to meet the cross-border needs of their multinational customers.
“Enterprise supply chains do not stop at national borders, and neither should the strategic tools and expertise required to optimize them,” said James Hallock, CoreTrust CEO. “International expansion represents a natural growth opportunity for CoreTrust, allowing us to continuously unlock new avenues of value for our members, private equity partners, and supplier network. CoreTrust Europe directly answers the call from both our members and supplier partners for borderless operational efficiency by bringing our model of aggregated spend and curated supplier performance to new markets to eliminate complexity, streamline sourcing, and capture real financial value.”
“Twenty years ago, we proved that aggregated spend could fundamentally change how North American enterprises manage indirect costs. Today, we see European organizations at that very same inflection point,” said Karin Manhardt, Vice President of Sales, Private Equity at CoreTrust. “The pull we’re feeling from our private equity partners and members tells us we’re just getting started. We have a long runway ahead in Europe, and we’re committed to scaling alongside our partners as their needs grow across the region."
CoreTrust Europe currently includes several global and regional supplier partners across essential indirect spend categories, including:
- FedEx – Small Parcel & Palletized Freight
- Lyreco – PPE, Hygiene, Catering, Workplace & Office Solutions
- Dell – IT Hardware (UK only)
- Enterprise Mobility – Car Rental & Flexible Long-Term Rental
- First Advantage – Background Screening
- Dayforce – HR, Pay, Time, Talent, and Planning
- NPI – IT Price Benchmarking and Negotiation Intelligence
- UKG – Workforce Operating Platform
For members, the international reach delivers a unified procurement experience across regions, combining local pricing and implementation support with CoreTrust’s established governance, analytics, and supplier vetting process. CoreTrust Europe is designed with members in mind, including:
- Private equity–backed portfolio companies with UK or EU operations,
- U.S.-based members expanding internationally, and
- UK-based organizations seeking enterprise-grade procurement leverage.
For suppliers, CoreTrust Europe opens access to aggregated multinational demand without the complexity of bespoke contracting on a member-by-member basis. Supplier partners see faster pipeline conversion, reduced sales friction, and the ability to scale alongside CoreTrust as the platform expands into new countries and categories.
“As CoreTrust accelerates its European presence, our collaboration demonstrates how the FedEx Intelligent Global Network delivers greater supply chain agility, visibility, and scale,” said Tracy Christoffersen, Vice President of Sales at FedEx. “Connecting more than 220 countries and territories, FedEx provides multinational organizations with the seamless connectivity they need to meet dynamic customer demands worldwide.”
“Lyreco is excited to play a central role in the CoreTrust Europe expansion, which allows us to engage with highly qualified global buyers through a single, standardized framework to support our clients’ workplace needs as they grow across regions,” said John Andrews, UK Head of International Accounts, Lyreco.
CoreTrust Europe leverages the company’s existing scale, supplier relationships, and internal maturity — including its analytics, contracting, and legal frameworks — to support international operations. CoreTrust will continue to expand the program with the addition of new markets, net-new spend categories, and broader supplier participation.
For more information on CoreTrust Europe, visit www.coretrustpg.com/who-we-serve/Europe.
About CoreTrust
CoreTrust is a premier strategic group purchasing organization (GPO) leveraging $7 billion in annual purchasing power to secure price stability and operational leverage on indirect spend for more than 4,000 impact-driven members. CoreTrust provides pre-negotiated contracts and specialized solutions across key enterprise categories, including corporate services, facilities, technology, and logistics, delivering curated supplier solutions and actionable insights to accelerate value realization. Learn more at www.coretrustpg.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260909827243/en/
Contacts
Minh Le
Minh.Le@coretrustpg.com
615-422-7661
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 10:15:00 CEST | Press Release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to disease biology is translating into meaningful clinical progress. Our GPC3 x 4-1BB bispecific antibody continues to be well tolerated and demonstrates durable activity with longer follow up in patients with heavily pre-treated hepatocellular carcinoma, while the first clinical data from our brain-penetrant PRMT5 inhibitor and CEA-targeting ADC expand our innovation in non-small cell lung cancer. Alongsi
Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press Release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (
Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:19:00 CEST | Press Release
Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press Release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta
inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press Release
inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom